Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

Shunji Hayashidani, Hiroyuki Tsutsui, Masaki Ikeuchi, Tetsuya Shiomi, Hidenori Matsusaka, Toru Kubota, Kyoko Imanaka-Yoshida, Takeshi Itoh, Akira Takeshita

Research output: Contribution to journalArticle

249 Citations (Scopus)

Abstract

Matrix metalloproteinase-2 (MMP-2) is prominently overexpressed both after myocardial infarction (MI) and in heart failure. However, its pathophysiological significance in these conditions is still unclear. We thus examined the effects of targeted deletion of MMP-2 on post-MI left ventricular (LV) remodeling and failure. Anterior MI was produced in 10- to 12-wk-old male MMP-2 knockout (KO) and sibling wild-type (WT) mice by ligating the left coronary artery. By day 28, MI resulted in a significant increase in mortality in association with LV cavity dilatation and dysfunction. The MMP-2 KO mice had a significantly better survival rate than WT mice (56% vs. 85%, P < 0.05), despite a comparable infarct size (50 ± 3% vs. 51 ± 3%, P = not significant), heart rate, and arterial blood pressure. The KO mice had a significantly lower incidence of LV rupture (10% vs. 39%, P < 0.05), which occurred within 7 days of MI. The KO mice exerted less LV cavity dilatation and improved fractional shortening after MI by echocardiography. The LV zymographic MMP-2 level significantly increased in WT mice after coronary artery ligation; however, this was completely prevented in KO mice. In contrast, the increase in the LV zymographic MMP-9 level after MI was similar between KO and WT mice. MMP-2 activation is therefore considered to contribute to an early cardiac rupture as well as late LV remodeling after MI. The inhibition of MMP-2 activation may therefore be a potentially useful therapeutic strategy to manage post-MI hearts.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume285
Issue number3 54-3
Publication statusPublished - Sep 1 2003

Fingerprint

Matrix Metalloproteinase 2
Rupture
Myocardial Infarction
Knockout Mice
Ventricular Remodeling
Dilatation
Coronary Vessels
Heart Rupture
Matrix Metalloproteinases
Ligation
Echocardiography
Arterial Pressure
Survival Rate
Heart Failure
Heart Rate
Mortality
Incidence

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. / Hayashidani, Shunji; Tsutsui, Hiroyuki; Ikeuchi, Masaki; Shiomi, Tetsuya; Matsusaka, Hidenori; Kubota, Toru; Imanaka-Yoshida, Kyoko; Itoh, Takeshi; Takeshita, Akira.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 285, No. 3 54-3, 01.09.2003.

Research output: Contribution to journalArticle

Hayashidani, Shunji ; Tsutsui, Hiroyuki ; Ikeuchi, Masaki ; Shiomi, Tetsuya ; Matsusaka, Hidenori ; Kubota, Toru ; Imanaka-Yoshida, Kyoko ; Itoh, Takeshi ; Takeshita, Akira. / Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. In: American Journal of Physiology - Heart and Circulatory Physiology. 2003 ; Vol. 285, No. 3 54-3.
@article{b84e5a36429e4a4eaa757868ec850668,
title = "Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction",
abstract = "Matrix metalloproteinase-2 (MMP-2) is prominently overexpressed both after myocardial infarction (MI) and in heart failure. However, its pathophysiological significance in these conditions is still unclear. We thus examined the effects of targeted deletion of MMP-2 on post-MI left ventricular (LV) remodeling and failure. Anterior MI was produced in 10- to 12-wk-old male MMP-2 knockout (KO) and sibling wild-type (WT) mice by ligating the left coronary artery. By day 28, MI resulted in a significant increase in mortality in association with LV cavity dilatation and dysfunction. The MMP-2 KO mice had a significantly better survival rate than WT mice (56{\%} vs. 85{\%}, P < 0.05), despite a comparable infarct size (50 ± 3{\%} vs. 51 ± 3{\%}, P = not significant), heart rate, and arterial blood pressure. The KO mice had a significantly lower incidence of LV rupture (10{\%} vs. 39{\%}, P < 0.05), which occurred within 7 days of MI. The KO mice exerted less LV cavity dilatation and improved fractional shortening after MI by echocardiography. The LV zymographic MMP-2 level significantly increased in WT mice after coronary artery ligation; however, this was completely prevented in KO mice. In contrast, the increase in the LV zymographic MMP-9 level after MI was similar between KO and WT mice. MMP-2 activation is therefore considered to contribute to an early cardiac rupture as well as late LV remodeling after MI. The inhibition of MMP-2 activation may therefore be a potentially useful therapeutic strategy to manage post-MI hearts.",
author = "Shunji Hayashidani and Hiroyuki Tsutsui and Masaki Ikeuchi and Tetsuya Shiomi and Hidenori Matsusaka and Toru Kubota and Kyoko Imanaka-Yoshida and Takeshi Itoh and Akira Takeshita",
year = "2003",
month = "9",
day = "1",
language = "English",
volume = "285",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3 54-3",

}

TY - JOUR

T1 - Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

AU - Hayashidani, Shunji

AU - Tsutsui, Hiroyuki

AU - Ikeuchi, Masaki

AU - Shiomi, Tetsuya

AU - Matsusaka, Hidenori

AU - Kubota, Toru

AU - Imanaka-Yoshida, Kyoko

AU - Itoh, Takeshi

AU - Takeshita, Akira

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Matrix metalloproteinase-2 (MMP-2) is prominently overexpressed both after myocardial infarction (MI) and in heart failure. However, its pathophysiological significance in these conditions is still unclear. We thus examined the effects of targeted deletion of MMP-2 on post-MI left ventricular (LV) remodeling and failure. Anterior MI was produced in 10- to 12-wk-old male MMP-2 knockout (KO) and sibling wild-type (WT) mice by ligating the left coronary artery. By day 28, MI resulted in a significant increase in mortality in association with LV cavity dilatation and dysfunction. The MMP-2 KO mice had a significantly better survival rate than WT mice (56% vs. 85%, P < 0.05), despite a comparable infarct size (50 ± 3% vs. 51 ± 3%, P = not significant), heart rate, and arterial blood pressure. The KO mice had a significantly lower incidence of LV rupture (10% vs. 39%, P < 0.05), which occurred within 7 days of MI. The KO mice exerted less LV cavity dilatation and improved fractional shortening after MI by echocardiography. The LV zymographic MMP-2 level significantly increased in WT mice after coronary artery ligation; however, this was completely prevented in KO mice. In contrast, the increase in the LV zymographic MMP-9 level after MI was similar between KO and WT mice. MMP-2 activation is therefore considered to contribute to an early cardiac rupture as well as late LV remodeling after MI. The inhibition of MMP-2 activation may therefore be a potentially useful therapeutic strategy to manage post-MI hearts.

AB - Matrix metalloproteinase-2 (MMP-2) is prominently overexpressed both after myocardial infarction (MI) and in heart failure. However, its pathophysiological significance in these conditions is still unclear. We thus examined the effects of targeted deletion of MMP-2 on post-MI left ventricular (LV) remodeling and failure. Anterior MI was produced in 10- to 12-wk-old male MMP-2 knockout (KO) and sibling wild-type (WT) mice by ligating the left coronary artery. By day 28, MI resulted in a significant increase in mortality in association with LV cavity dilatation and dysfunction. The MMP-2 KO mice had a significantly better survival rate than WT mice (56% vs. 85%, P < 0.05), despite a comparable infarct size (50 ± 3% vs. 51 ± 3%, P = not significant), heart rate, and arterial blood pressure. The KO mice had a significantly lower incidence of LV rupture (10% vs. 39%, P < 0.05), which occurred within 7 days of MI. The KO mice exerted less LV cavity dilatation and improved fractional shortening after MI by echocardiography. The LV zymographic MMP-2 level significantly increased in WT mice after coronary artery ligation; however, this was completely prevented in KO mice. In contrast, the increase in the LV zymographic MMP-9 level after MI was similar between KO and WT mice. MMP-2 activation is therefore considered to contribute to an early cardiac rupture as well as late LV remodeling after MI. The inhibition of MMP-2 activation may therefore be a potentially useful therapeutic strategy to manage post-MI hearts.

UR - http://www.scopus.com/inward/record.url?scp=0041858010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041858010&partnerID=8YFLogxK

M3 - Article

VL - 285

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 3 54-3

ER -